Live Breaking News & Updates on Rckt

Stay informed with the latest breaking news from Rckt on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Rckt and stay connected to the pulse of your community

Rocket Pharmaceuticals (NASDAQ:RCKT) Upgraded at StockNews.com

StockNews.com upgraded shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) to a sell rating in a research note published on Saturday. A number of other brokerages have also issued reports on RCKT. Chardan Capital lowered their target price on shares of Rocket Pharmaceuticals from $63.00 to $61.00 in a research report on Friday, May 5th. […]

Metlife-investment-management , Hightower-advisors , Rocket-pharmaceuticals , Analyst-recommendations-for-rocket-pharmaceuticals , Synovus-financial-corp , Needham-company , Nasdaq , Rocket-pharmaceuticals-stock-performance , Hedge-funds-weigh-in-on-rocket-pharmaceuticals , Rocket-pharmaceuticals-inc , Jpmorgan-chase-co

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Insider John Militello Sells 573 Shares

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) insider John Militello sold 573 shares of the firm’s stock in a transaction on Thursday, July 20th. The shares were sold at an average price of $19.03, for a total transaction of $10,904.19. Following the completion of the transaction, the insider now directly owns 7,129 shares in […]

John-militello , Rocket-pharmaceuticals-company-profile , Rocket-pharmaceuticals-inc , Synovus-financial-corp , Rocket-pharmaceuticals , Institutional-investors-weigh-in-on-rocket-pharmaceuticals , News-ratings-for-rocket-pharmaceuticals-daily , Nasdaq , Hightower-advisors , Jpmorgan-chase-co , Needham-company , Rocket-pharmaceuticals-stock-down

Rocket Pharmaceuticals (NASDAQ:RCKT) Upgraded by StockNews.com to "Sell"

StockNews.com upgraded shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) to a sell rating in a report released on Saturday morning. RCKT has been the topic of several other reports. Needham & Company LLC reaffirmed a buy rating and issued a $60.00 target price on shares of Rocket Pharmaceuticals in a research report on Wednesday, […]

Blackrock , New-zealand-general- , New-zealand , Wellington , Hedge-funds-weigh-in-on-rocket-pharmaceuticals , News-ratings-for-rocket-pharmaceuticals-daily , Vanguard-group-inc , Analyst-recommendations-for-rocket-pharmaceuticals , Rocket-pharmaceuticals , Maverick-capital-ltd , Blackrock-inc

Rocket Pharmaceuticals (NASDAQ:RCKT) Upgraded to "Sell" at StockNews.com

StockNews.com upgraded shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) to a sell rating in a report issued on Friday morning. Several other analysts have also issued reports on RCKT. Needham & Company LLC restated a buy rating and issued a $60.00 price objective on shares of Rocket Pharmaceuticals in a report on Wednesday, April […]

William-blair , John-militello , Hedge-funds-weigh-in-on-rocket-pharmaceuticals , Kokusai-asset-management-co , Wells-fargo-company , Analyst-recommendations-for-rocket-pharmaceuticals , Rocket-pharmaceuticals , Rocket-pharmaceuticals-company-profile , Needham-company , Mitsubishi-ufj , News-ratings-for-rocket-pharmaceuticals-daily , Rocket-pharmaceuticals-inc

Rocket Pharmaceuticals (NASDAQ:RCKT) Upgraded by StockNews.com to "Sell"

StockNews.com upgraded shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) to a sell rating in a research note released on Friday morning. A number of other research analysts have also weighed in on the company. William Blair reaffirmed an outperform rating on shares of Rocket Pharmaceuticals in a report on Wednesday, March 22nd. Chardan Capital […]

John-militello , William-blair , News-ratings-for-rocket-pharmaceuticals-daily , Rocket-pharmaceuticals , Securities-exchange-commission , Rocket-pharmaceuticals-inc , Needham-company , Analyst-recommendations-for-rocket-pharmaceuticals , Rocket-pharmaceuticals-company-profile , Synovus-financial-corp , Jpmorgan-chase-co , Institutional-trading-of-rocket-pharmaceuticals

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Recommendation of "Buy" by Brokerages

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) has earned an average rating of “Buy” from the twelve analysts that are covering the company, MarketBeat.com reports. Twelve research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is […]

John-militello , William-blair , Pura-vida-investments , Analyst-recommendations-for-rocket-pharmaceuticals , Synovus-financial-corp , Rocket-pharmaceuticals-inc , News-ratings-for-rocket-pharmaceuticals-daily , Rocket-pharmaceuticals-stock-down , Rocket-pharmaceuticals , Needham-company , Privium-fund-management , Nasdaq

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Rating) have been assigned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating and eleven have assigned a buy rating to the company. The average 1-year […]

Blackrock , New-zealand-general- , New-zealand , Wellington , John-militello , William-blair , Rocket-pharmaceuticals-inc , Analyst-recommendations-for-rocket-pharmaceuticals , Institutional-investors-weigh-in-on-rocket-pharmaceuticals , Rocket-pharmaceuticals-stock-performance , Wellington-management-group , Maverick-capital-ltd

Sectoral Asset Management Inc. Sells 80,000 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)

Sectoral Asset Management Inc. lowered its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Rating) by 29.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 190,790 shares of the biotechnology company’s stock after selling 80,000 shares during the quarter. […]

Hong-kong , John-militello , William-blair , Allspring-global-investments-holdings , Securities-exchange-commission , Clear-harbor-asset-management , Quarter-for-rocket-pharmaceuticals , Hong-kong-ltd , Advisor-group-holdings-inc , Sectoral-asset-management-inc , Rocket-pharmaceuticals-inc , Morgan-stanley

StockNews.com Begins Coverage on Rocket Pharmaceuticals (NASDAQ:RCKT)

Research analysts at StockNews.com initiated coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. A number of other analysts have also recently issued reports on the company. William Blair reiterated an “outperform” […]

John-militello , William-blair , Institutional-trading-of-rocket-pharmaceuticals , Clearstead-advisors , Morgan-stanley , Rocket-pharmaceuticals-stock , Great-west-life-assurance-co , News-ratings-for-rocket-pharmaceuticals-daily , Rocket-pharmaceuticals-inc , Rocket-pharmaceuticals , Advisor-group-holdings-inc , Insider-transactions-at-rocket-pharmaceuticals

Rocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) in a report issued on Thursday. The firm issued a sell rating on the biotechnology company’s stock. RCKT has been the topic of several other research reports. Morgan Stanley initiated coverage on shares of Rocket Pharmaceuticals in a research report on Wednesday, February […]

Blackrock , New-zealand-general- , New-zealand , Wellington , William-blair , John-militello , Wellington-management-group , Rocket-pharmaceuticals-inc , Vanguard-group-inc , Rocket-pharmaceuticals-stock-performance , Rocket-pharmaceuticals , Needham-company